leads to severe renal salt wasting (Bartter syndrome type IV) and sensorineural deafness. 13, 14 Partial loss-of-function mutations of barttin may result in nonsyndromal hearing loss. 15 ClC-K/barttin channels are under control of multiple signal cascades. ClC-K/barttin is inhibited by acid pH and stimulated by extracellular calcium. 13, 16 The ClC-K/barttin channel complexes may be targeted by the ubiquitin ligase Nedd4-2, which presumably ubiquitinates the channel proteins, thus labeling them for proteosomal degradation. 17 Nedd4-2 is phosphorylated by serum and glucocorticoid-inducible kinase 1. 2,17 Phosphorylated Nedd4-2 is bound to the scaffolding protein 14-3-3, which prevents its interaction with the channel proteins. Accordingly, serum and glucocorticoid-inducible kinase 1 upregulates ClC-Ka. 17, 18 Dehydration upregulates ClC-K1 expression, and salt depletion upregulates ClC-K2 expression. Furosemide has differing effects on ClC-K1 and ClC-K2. It upregulates ClC-K2 but downregulates ClC-K1 expression. 2 ClC-K1 expression is markedly downregulated and urinary concentrating ability impaired in animals lacking tissue angiotensin-converting enzyme. 19 ClC-K2 is downregulated by (uro)guanylin. 20 After excision of channel-containing membrane patches, the ClC-K/barttin channels close. Apparently, some cellular component, such as cytoskeleton, is required to maintain the channels in the open configuration. 21 Barttin exerts multiple effects in ClC-K channel function. It modifies ClC-K protein stability, subcellular distribution, and voltage-dependent gating. 13, 16, 21 In this issue of JASN, Fischer et al. 21 used heterologous expression in mammalian cells and patch-clamp to study the biophysical effects of barttin on rat ClC-K1 and human ClC-Ka. They compared the currents generated by expression of ClC-K1 with or without additional barttin expression. ClC-K channels are double-barreled channels with two identical protopores that are governed by individual or common gating. In the absence of barttin, Fischer et al. 21 observed two gating processes with distinct kinetics and voltage dependence. A fast gating process, activated by membrane hyperpolarization, was shown to open and close individual ClC-K1 protopores. In contrast, a slow gating step, stimulated by membrane depolarization, regulated the common gating of the two protopores. Notably, the protopores displayed fast gating, even though ClC-K channels lack the "gating" glutamate at the amino-terminal end of the F-helix, which is considered to underlie the fast protopore gating in other ClC channels. 21 Upon co-transfection with barttin, the channels displayed only one gating process that resembled macroscopic fast gating of the same channel in the absence of barttin. In the presence of barttin, the open probability of the slow gate lost voltage dependence and remained constitutively open. Accordingly, barttin increased channel activity at physiologic potentials. Human ClC-Ka was functional only after coexpression with barttin. The authors conclude that barttin constitutively opens the common slow gate of ClC-K/barttin channels.
The article by Fischer et al. 21 provides novel insight into the biophysical properties of the ClC-K channels and their modification by the accessory subunit barttin. The observations not only are relevant for the function of ClC-K channels but also significantly expand on our knowledge on the function of ClC channels in general. ClC chloride channels are voltage-gated channels, but the physiologic significance of these gating processes has been largely unclear. The study by Fischer et al. 21 establishes that barttin modifies the function of ClC-K channels and optimizes epithelial transport by modulating gating. Barttin also reveals the first biological function of cooperative gating of ClC channels. The peculiar double-barreled structure of ClC channels and the existence of individual and cooperative gating processes have attracted a lot of interest in recent years. Fischer et al. 21 now demonstrate that modification of epithelial transport by barttin is achieved through changed cooperative gating. ClC channel gating is dysfunctional in various genetic diseases, and novel therapeutic approaches addressing ClC channels might be helpful in treating those diseases. The identification of barttin-binding sites could be a first step for a rational design in the development of ClC activators or blockers.
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